PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Alpha-Glucosidase 4,319 Target Drug Alglucosidase Alfa (Myozyme)- FDA 4 2 0.02 -0.71 0.50 0.69
Dragmacidins 4 Drug Drug Dragmacidin D 4 2 0.50 -0.50 0.50 0.96
Ancobon (Flucytosine)- FDA 4 Drug Drug Amphotericin B (Fungizone)- FDA 30 2 0.18 -0.68 0.50 0.86
Allergic Rhinitis 12,280 Disease Drug Azelastine hydrochloride (Optivar)- FDA 4 2 0.01 -0.71 0.50 0.66
Alocril (Nedocromil)- FDA 4 Drug Disease Asthma 109,610 2 0.00 -0.71 0.50 0.61
Hepatitis Chronic Active 6 Disease Disease Liver Disease 49,817 3 0.01 -0.71 0.50 0.63
ADRBK2 8 Target Target Beta-Adrenergic Receptor Kinase 2 15 4 0.37 -0.61 0.50 0.93
Carcinoma Basal Cell 8 Disease Disease Skin Cancer 11,561 4 0.01 -0.71 0.50 0.67
Cancer 1,053,491 Disease Target Prostaglandin Reductase 1 8 4 0.00 -0.71 0.50 0.57
Prostate Cancer 71,064 Disease Target Aldo-Keto Reductase Family 1 Member C3 8 4 0.01 -0.71 0.50 0.63
BNP 6,842 Target Target Brain (B-type) Natriuretic Protein 8 4 0.02 -0.71 0.50 0.69
Carcinoma 433,099 Disease Drug Axitinib (Inlyta)- FDA 10 5 0.00 -0.71 0.50 0.59
Cancer 1,053,491 Disease Drug Aflibercept (Eylea)- FDA 14 7 0.00 -0.71 0.50 0.57
Cancer 1,053,491 Disease Drug Amifostine (Ethyol)- FDA 14 7 0.00 -0.71 0.50 0.57
Arthritis 128,324 Disease Drug Abatacept (Orencia)- FDA 18 9 0.01 -0.71 0.50 0.62
Anemia 81,663 Disease Drug Aranesp (Darbepoetin Alfa)- FDA 20 10 0.01 -0.71 0.50 0.63
Aricept (Donepezil Hydrochloride)- FDA 32 Drug Disease Dementia 66,782 16 0.01 -0.71 0.50 0.64
Aldara (Imiquimod)- FDA 36 Drug Disease Warts 5,574 18 0.04 -0.71 0.50 0.72
EPHB3 118 Target Target EPHB2 385 59 0.28 -0.65 0.50 0.88
Adalimumab (Humira)- FDA 62 Drug Disease Arthritis 128,324 32 0.01 -0.70 0.52 0.63
Epigen 27 Target Target EGF 27,487 14 0.02 -0.69 0.52 0.67
ANGPT1 81 Target Target ANGPT2 105 42 0.46 -0.54 0.52 0.94
CCL19 658 Target Target CCL21 808 344 0.47 -0.52 0.52 0.93
Cancer 1,053,491 Disease Target Aurora Kinase A 196 103 0.01 -0.69 0.53 0.59
Cancer 1,053,491 Disease Target Kallikrein-8 19 10 0.00 -0.69 0.53 0.57
Infection 766,637 Disease Target Tegument Protein Vp16 19 10 0.00 -0.69 0.53 0.58
Eotaxin-3/CCL26 26 Target Target Eotaxin-2/CCL24 19 10 0.45 -0.54 0.53 0.94
Anxiety 113,510 Disease Disease Panic Attack 823 434 0.04 -0.69 0.53 0.68
Cytokeratin 20 847 Target Disease Carcinoma 433,099 449 0.02 -0.69 0.53 0.63
Cancer 1,053,491 Disease Target Carbonic Anhydrase 9 150 80 0.01 -0.68 0.53 0.59
Non Small Cell Lung Cancer 28,563 Disease Drug Alimta (Pemetrexed)- FDA 28 15 0.02 -0.68 0.54 0.67
Alimta (Pemetrexed)- FDA 28 Drug Disease Mesothelioma 11,198 15 0.03 -0.68 0.54 0.70
Maternal Embryonic Leucine Zipper Kinase 39 Target Disease Cancer 1,053,491 21 0.00 -0.68 0.54 0.58
Panic Attack 823 Disease Disease Panic Disorder 7,455 444 0.18 -0.66 0.54 0.81
Seizure 44,685 Disease Disease Seizures 66,465 24,188 0.44 -0.54 0.54 0.88
Infection 766,637 Disease Disease Genital Herpes 2,660 1,442 0.03 -0.68 0.54 0.63
Acne 11,364 Disease Disease SAPHO Syndrome 378 205 0.10 -0.67 0.54 0.76
ERK1 18,374 Target Target ERK2 3,287 1,788 0.23 -0.64 0.54 0.82
Epilepsy 71,172 Disease Disease Seizures Partial 11 6 0.01 -0.67 0.55 0.63
Epidermal Growth Factor Receptor 24,772 Target Disease Cancer 1,053,491 13,587 0.08 -0.67 0.55 0.66
Leukemias 14,152 Disease Disease Leukemia 162,805 7,764 0.16 -0.66 0.55 0.74
Sacroiliac Joint Pain 133 Disease Disease Back Pain 30,003 73 0.04 -0.67 0.55 0.69
Diabetes 332,602 Disease Disease Hyperglycemia 28,168 15,545 0.16 -0.65 0.55 0.73
Diabetes 332,602 Disease Disease Diabetic Nephropathy 12,496 6,932 0.11 -0.66 0.55 0.70
CD4 112,219 Target Target CD254 9 5 0.00 -0.67 0.56 0.62
CXCL10 2,386 Target Target CXCL4/PF4 9 5 0.03 -0.67 0.56 0.72
Epiregulin 291 Target Target EGF 27,487 162 0.06 -0.66 0.56 0.71
CXCL9 1,016 Target Target CXCL11 526 293 0.40 -0.56 0.56 0.91
CXCL3 145 Target Target CXCL2 750 81 0.25 -0.63 0.56 0.86
AKT2 873 Target Target AKT3 293 164 0.32 -0.60 0.56 0.88